EDUCATION CORNER

EEG Signature(s): Propofol with Ketamine

By: Dr. Eben Smitherman & Dr. Sonal Sharma


Dr. Eben Smitherman
Anesthesiology Resident
Penn State Health Milton S. Hershey Medical Center


Dr. Sonal Sharma
Assistant Professor
Penn State Health Milton S. Hershey Medical Center

Ketamine is used for its hypnotic and analgesic properties. It works through antagonizing the N-methyl-D-aspartate (NMDA) receptor in the central nervous system. Ketamine has a beneficial role in anesthesia practice as both a primary anesthetic and as an adjunct.  When combined with propofol, it lowers the overall propofol dose and provides analgesia.

Propofol binds post-synaptically to γ-aminobutyric acid type A (GABAA) receptors where it induces an inward chloride current that hyperpolarizes the postsynaptic neurons, leading to inhibition. In the cortex, propofol induces inhibition of pyramidal neurons. It also decreases excitatory inputs from the thalamus to the cortex by inhibition at the thalamic reticular nucleus. Because the thalamus and cortex are highly interconnected, the inhibitory effects of propofol lead to dose dependent oscillations in the delta and alpha ranges. Propofol also decreases excitatory inputs from the thalamus and the brainstem to the cortex which enhances hyperpolarization of cortical pyramidal neurons, an effect that favors the appearance of slow and delta oscillations.

Ketamine, on the other hand, acts primarily by binding to N-methyl-d-aspartate (NMDA) receptors in the brain and spinal cord. Ketamine at low-to-moderate doses primarily blocks inputs to inhibitory interneurons, allowing downstream excitatory neurons to become disinhibited resulting in an active electroencephalogram pattern showing fast oscillations in the high beta, low gamma range between 25 and 32 Hz. Compared with propofol, the ketamine slow oscillation is less regular. As the dose of ketamine is increased, the NMDA receptors on the excitatory glutamatergic neurons are also blocked, resulting in loss of consciousness.

When ketamine is administered with propofol, there is a power shift to the beta bandwidth (13-30 Hz). The power of the alpha band that is normally observed with propofol when it is administered alone will decrease in power because of the higher frequency of cortical brain activity caused by ketamine.

The readout of EEG density spectral array monitoring displays frequency on the y-axis and time on the x-axis. Frequency of brain activity is quantified by color changes, with blue representing the lowest power, red representing the highest power with intermediate powers ranging from green to yellow.

Case Example:

A 56-year-old female underwent an anterior-posterior lumbar spinal fusion. Following induction and intubation, anesthesia was maintained with propofol and remifentanil infusions. Ketamine was added to the infusions later via low dose infusion following a low dose bolus approximately 80 minutes after induction.

Figure 1: 9:44 – 10:14

Figure 1 demonstrates the spectrograph pattern associated with propofol. Note the increased power in the ranges of alpha (8 – 10Hz), delta (1 – 4Hz), and slow (0.1 – 1Hz) wave ranges. During this time -period, propofol and remifentanil were the sole infusions. Remifentanil does not significantly affect the EEG pattern of propofol.


Figure 2: 10:26 – 10:56

In figure 2, at 10:42, approximately 80 minutes after induction and 30 minutes after surgical incision, a bolus of 0.3mg/kg of ketamine was administered followed immediately after by the initiation of a ketamine infusion at 0.1mg/kg/hr. Note the increased power in beta range (14-30Hz) with the activity almost nearing that of gamma (>30Hz) along with the coinciding decrease in power in the alpha range. The slow-delta pattern (0.1 – 4Hz) remains but becomes less regular with time as displayed in Figure 3.


Figure 3: 12:42 – 13:12

Figure 3 shows the EEG pattern after 2.5hrs of low dose ketamine infusion combined with propofol and remifentanil, just prior to stopping ketamine. Despite the low dose ketamine infusion, the power in the beta range continues to be present and the slow delta patterns persists.

Additional Resources:

  1. Akeju O, Song AH, Hamilos AE, et al. Electroencephalogram signatures of ketamine anesthesia-induced unconsciousness. Clin Neurophysiol. 2016;127(6):2414-2422. doi: 10.1016/j.clinph.2016.03.005
  2. Barrett W, Buxhoeveden M, Dhillon S. Ketamine: A versatile tool for anesthesia and Analgesia. Current Opinion in Anaesthesiology. 2020;33(5):633-638. doi:10.1097/aco.0000000000000916
  3. Papangelou A, Nelson P. SNACC News. https://snacc.org/newsletter/12385/?d1-text. Published May 15, 2023.
  4. Purdon PL, Sampson A, Pavone KJ, Brown, EN. Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures. Anesthesiology. 2015; 123:937–960.doi: 10.1097/ALN.000000000000084
  5. Schwenk ES, Viscusi ER, Buvanendran A et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Regional Anesthesia and Pain Medicine. 2018; 43(5): 456-66. doi:10.1097/aap.0000000000000806

Back to top